[96a5a0]: / output / allTrials / identified / NCT00231582_identified.json

Download this file

559 lines (559 with data), 23.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
{
"info": {
"nct_id": "NCT00231582",
"official_title": "Sequential High-Dose Chemotherapy Combining Two Mobilization and Cyto-Reductive Treatments Followed by Three High-Dose Chemotherapy Regimens Supported by Autologous Stem Cell Transplantation",
"inclusion_criteria": "Eligibility requirements includes the following criteria:\n\n* Age >18 years and < 65\n* Performance status < 3\n* Histologically or biologically documented GCTs\n* Testicular, abdominal, or mediastinal tumors\n* Measurable or evaluable disease\n* Life expectancy > 3 months\n* Normal cardiac, liver, and renal function tests\n* Absence of infection\n* HIV negative test\n* Signed informed consent\n* All patients had to have been previously treated with at least one line of a cisplatin-containing regimen and were included if they were refractory after one or two line(s) of cisplatin-based CT, or had relapsed after two lines of a cisplatin-based CT\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 65 Years",
"exclusion_criteria": "* Fireproof diseases (progress unless month with regard to the last cycle of chemotherapy or in the course of chemotherapy)\n* Relapses after complete answer obtained by surgery ( sCR )\n* Neuropathy of superior rank or = II - renal Function (Office) superior creatinine or = 125 mmol/l and/or clearance of the creatinine subordinate or = II 60ml / mn\n* Antecedents of congestive even compensated cardiac insufficiency\n* Hurts of growing teratoma that is measurable hurts increasing by size (cutting) in the absence of rise of marker pens\n* Extensive chemotherapy with support of haematopoietic stem cells. NB: A previous preventive irradiation under diaphragmatitis for a seminoma stage I (dose from 24 to 30 Gy in classic spreading) does not establish one against formal indication. However, an estimation clarifies capacities of the haematopoietic marrow is recommended with observation of the evolution of the NFP in the course of chemotherapy and quantification of cells CD 34 + in the peripheral blood. It's the same of the case where a chemotherapy by carboplatine was realized",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Age >18 years and < 65",
"criterions": [
{
"exact_snippets": "Age >18 years and < 65",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">",
"value": 18,
"unit": "years"
},
{
"operator": "<",
"value": 65,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Performance status < 3",
"criterions": [
{
"exact_snippets": "Performance status < 3",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Histologically or biologically documented GCTs",
"criterions": [
{
"exact_snippets": "Histologically or biologically documented GCTs",
"criterion": "GCTs documentation",
"requirements": [
{
"requirement_type": "method",
"expected_value": [
"histologically",
"biologically"
]
}
]
}
]
},
{
"line": "* Testicular, abdominal, or mediastinal tumors",
"criterions": [
{
"exact_snippets": "Testicular",
"criterion": "testicular tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "abdominal",
"criterion": "abdominal tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "mediastinal tumors",
"criterion": "mediastinal tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Measurable or evaluable disease",
"criterions": [
{
"exact_snippets": "Measurable or evaluable disease",
"criterion": "disease",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": [
"measurable",
"evaluable"
]
}
]
}
]
},
{
"line": "* Life expectancy > 3 months",
"criterions": [
{
"exact_snippets": "Life expectancy > 3 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Normal cardiac, liver, and renal function tests",
"criterions": [
{
"exact_snippets": "Normal cardiac ... function tests",
"criterion": "cardiac function",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "Normal ... liver ... function tests",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "Normal ... renal function tests",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
}
]
},
{
"line": "* Absence of infection",
"criterions": [
{
"exact_snippets": "Absence of infection",
"criterion": "infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* HIV negative test",
"criterions": [
{
"exact_snippets": "HIV negative test",
"criterion": "HIV status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Signed informed consent",
"criterions": [
{
"exact_snippets": "Signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "* All patients had to have been previously treated with at least one line of a cisplatin-containing regimen and were included if they were refractory after one or two line(s) of cisplatin-based CT, or had relapsed after two lines of a cisplatin-based CT",
"criterions": [
{
"exact_snippets": "previously treated with at least one line of a cisplatin-containing regimen",
"criterion": "previous treatment with cisplatin-containing regimen",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "line"
}
}
]
},
{
"exact_snippets": "refractory after one or two line(s) of cisplatin-based CT",
"criterion": "refractory status after cisplatin-based CT",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1,
"unit": "line"
},
{
"operator": "<=",
"value": 2,
"unit": "lines"
}
]
}
}
]
},
{
"exact_snippets": "relapsed after two lines of a cisplatin-based CT",
"criterion": "relapsed status after cisplatin-based CT",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "=",
"value": 2,
"unit": "lines"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 65 Years",
"criterions": [
{
"exact_snippets": "maximum age of 65 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 65,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Fireproof diseases (progress unless month with regard to the last cycle of chemotherapy or in the course of chemotherapy)",
"criterions": [
{
"exact_snippets": "Fireproof diseases (progress unless month with regard to the last cycle of chemotherapy or in the course of chemotherapy)",
"criterion": "fireproof diseases",
"requirements": [
{
"requirement_type": "progression",
"expected_value": "unless month with regard to the last cycle of chemotherapy or in the course of chemotherapy"
}
]
}
]
},
{
"line": "* Relapses after complete answer obtained by surgery ( sCR )",
"criterions": [
{
"exact_snippets": "Relapses after complete answer obtained by surgery ( sCR )",
"criterion": "relapse after surgery",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Neuropathy of superior rank or = II - renal Function (Office) superior creatinine or = 125 mmol/l and/or clearance of the creatinine subordinate or = II 60ml / mn",
"criterions": [
{
"exact_snippets": "Neuropathy of superior rank or = II",
"criterion": "neuropathy",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "rank"
}
}
]
},
{
"exact_snippets": "renal Function (Office) superior creatinine or = 125 mmol/l",
"criterion": "creatinine level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 125,
"unit": "mmol/l"
}
}
]
},
{
"exact_snippets": "clearance of the creatinine subordinate or = II 60ml / mn",
"criterion": "creatinine clearance",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "ml/mn"
}
}
]
}
]
},
{
"line": "* Antecedents of congestive even compensated cardiac insufficiency",
"criterions": [
{
"exact_snippets": "Antecedents of congestive even compensated cardiac insufficiency",
"criterion": "congestive cardiac insufficiency",
"requirements": [
{
"requirement_type": "antecedents",
"expected_value": true
}
]
},
{
"exact_snippets": "Antecedents of ... compensated cardiac insufficiency",
"criterion": "compensated cardiac insufficiency",
"requirements": [
{
"requirement_type": "antecedents",
"expected_value": true
}
]
}
]
},
{
"line": "* Hurts of growing teratoma that is measurable hurts increasing by size (cutting) in the absence of rise of marker pens",
"criterions": [
{
"exact_snippets": "Hurts of growing teratoma that is measurable",
"criterion": "growing teratoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "measurability",
"expected_value": true
}
]
},
{
"exact_snippets": "hurts increasing by size (cutting)",
"criterion": "hurts",
"requirements": [
{
"requirement_type": "size",
"expected_value": "increasing"
}
]
},
{
"exact_snippets": "absence of rise of marker pens",
"criterion": "marker pens",
"requirements": [
{
"requirement_type": "rise",
"expected_value": false
}
]
}
]
},
{
"line": "* Extensive chemotherapy with support of haematopoietic stem cells. NB: A previous preventive irradiation under diaphragmatitis for a seminoma stage I (dose from 24 to 30 Gy in classic spreading) does not establish one against formal indication. However, an estimation clarifies capacities of the haematopoietic marrow is recommended with observation of the evolution of the NFP in the course of chemotherapy and quantification of cells CD 34 + in the peripheral blood. It's the same of the case where a chemotherapy by carboplatine was realized",
"criterions": [
{
"exact_snippets": "Extensive chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "extent",
"expected_value": "extensive"
}
]
},
{
"exact_snippets": "support of haematopoietic stem cells",
"criterion": "haematopoietic stem cells",
"requirements": [
{
"requirement_type": "support",
"expected_value": true
}
]
},
{
"exact_snippets": "estimation clarifies capacities of the haematopoietic marrow",
"criterion": "haematopoietic marrow capacity",
"requirements": [
{
"requirement_type": "estimation",
"expected_value": true
}
]
},
{
"exact_snippets": "observation of the evolution of the NFP in the course of chemotherapy",
"criterion": "NFP evolution",
"requirements": [
{
"requirement_type": "observation",
"expected_value": true
}
]
},
{
"exact_snippets": "quantification of cells CD 34 + in the peripheral blood",
"criterion": "CD 34+ cells in peripheral blood",
"requirements": [
{
"requirement_type": "quantification",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Eligibility requirements includes the following criteria:",
"criterions": []
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}